CD&R, McKesson Corporation (NYSE: MCK) ("McKesson"), and Option Care Health, Inc. (Nasdaq: OPCH) ("Option Care Health") announced today that they have entered into a definitive agreement, under which ...
Option Care Health provides home and alternate site infusion services in all 50 US states, with more than 8,000 staff including over 5,000 clinicians.
According to sources cited by Reuters in October 2025, the business could be worth more than £1bn ($1.34bn).
CD&R's strategic investment will further support FBM's compelling long-term growth opportunity; American Securities retains majority stake NEW YORK, Jan. 31, 2024 /PRNewswire/ -- Clayton, Dubilier & ...
Clayton, Dubilier & Rice’s long-established history with HD Supply and Sterling Group positioned it to combine two construction distribution businesses in one of the largest industrial LBOs during the ...
CD&R, McKesson ( MCK) and Option Care Health ( OPCH) have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health for $32.05 per share, reflecting a total ...